Intraocular lymphoma as relapse after chemotherapy for primary breast diffuse large B-cell lymphoma
Journal of Clinical and Experimental Hematopathology · 2018 · 58 (4) · 180-183
DOI: 10.3960/jslrt.18026 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2018. Verfasst von Toshihiko Matsuo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology, Okayama University Hospital, Okayama City, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Eye Neoplasms, Lymphoma, Large B-Cell, Diffuse, Neoplasms, Second Primary. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ophthalmology, Okayama University Hospital, Okayama City, Japan.
- Pathology, Okayama University Hospital, Okayama City, Japan.
- Hematology and Oncology, Okayama Rosai Hospital, Okayama City, Japan.
Zitieren
APA
Matsuo, T., Tanaka, T., & Yano, T. (2018). Intraocular lymphoma as relapse after chemotherapy for primary breast diffuse large B-cell lymphoma. Journal of Clinical and Experimental Hematopathology, 58(4), 180-183. https://doi.org/10.3960/jslrt.18026
Vancouver
Matsuo T, Tanaka T, Yano T. Intraocular lymphoma as relapse after chemotherapy for primary breast diffuse large B-cell lymphoma. Journal of Clinical and Experimental Hematopathology. 2018;58(4):180-183. doi:10.3960/jslrt.18026
BibTeX
@article{Matsuo2018,
author = {Matsuo, Toshihiko and Tanaka, Takehiro and Yano, Tomofumi},
title = {Intraocular lymphoma as relapse after chemotherapy for primary breast diffuse large B-cell lymphoma},
journal = {Journal of Clinical and Experimental Hematopathology},
year = {2018},
volume = {58},
number = {4},
pages = {180--183},
doi = {10.3960/jslrt.18026}
}
EUVIMED